Covered recipient · General Payments record
SILVIA P CORONEL-FIGUEROA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$751.14
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $225.66 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $86.35 | 5 |
| PFIZER INC. | $43.80 | 2 |
| Lundbeck LLC | $29.34 | 1 |
| Edwards Lifesciences Corporation | $25.25 | 1 |
| SHIELD THERAPEUTICS INC | $21.87 | 1 |
| Sumitomo Pharma America, Inc. | $19.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | $25.25 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138791750 | CMS |
| Lundbeck LLC | $29.34 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145907245 | CMS |
| Novo Nordisk Inc | $16.87 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096930892 | CMS |
| Novo Nordisk Inc | $15.67 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097089630 | CMS |
| Novo Nordisk Inc | $19.38 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096936141 | CMS |
| Novo Nordisk Inc | $19.38 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097391854 | CMS |
| Novo Nordisk Inc | $15.05 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097065659 | CMS |
| PFIZER INC. | $21.50 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131799317 | CMS |
| PFIZER INC. | $22.30 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131831966 | CMS |
| SHIELD THERAPEUTICS INC | $21.87 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150156526 | CMS |
| Sumitomo Pharma America, Inc. | $19.05 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148840608 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.